We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Acadia Pharmaceuticals Inc | NASDAQ:ACAD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.03 | -0.18% | 17.05 | 16.90 | 31.00 | 17.5839 | 17.03 | 17.44 | 1,160,279 | 05:00:00 |
(b) Effective March 29, 2017, Terrence Moore retired from his position as Executive Vice President, Chief Commercial Officer of ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. |
By: | /s/ Glenn F. Baity |
|
|
Name: Glenn F. Baity | |
Title: EVP, General Counsel & Secretary |
1 Year Acadia Pharmaceuticals Chart |
1 Month Acadia Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions